title: Pelvic sonography can predict ovum release in gonadotrophin-treated patients as determined by pregnancy rate.
abstract: Ultrasonographic monitoring of ovum release was performed in two consecutive cycles in each of 220 patients treated with gonadotrophin. Definite release occurred in 69% of cycles, indeterminate in 24% and non-release in 7%. Support for the accuracy of sonography in diagnosing the luteinized unruptured follicle (LUF) was demonstrated by a much higher pregnancy rate in those patients showing ovum release. There was a definite tendency for non-release to recur in the next cycle. Thus, the data support the routine use of sonography 2-3 days after human chorionic gonadotrophin (HCG) injection to monitor ovum release in gonadotrophin-treated patients (HMG).
authors.affiliation: UMDNJ, Robert Wood Johnson Medical School, Camden, NJ.
authors.forename: J H
authors.initials: JH
authors.lastname: Check
authors.forename: H G
authors.initials: HG
authors.lastname: Adelson
authors.forename: C
authors.initials: C
authors.lastname: Dietterich
authors.forename: J
authors.initials: J
authors.lastname: Stern
mesh_terms: D006063:Chorionic Gonadotropin / Q000494:pharmacology; D005260:Female; D006801:Humans; D008183:Luteal Phase / Q000502:physiology; D008596:Menotropins / Q000494:pharmacology / Q000627:therapeutic use; D006080:Ovarian Follicle / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D012189:Retrospective Studies; D014463:Ultrasonography
chemical_list: D006063:Chorionic Gonadotropin; D008596:Menotropins